The FDA has approved durvalumab (Imfinzi, AstraZeneca) in combination with Bacillus Calmette-Guerin (BCG) for adults with BCG-naive, high-risk non-muscle-invasive bladder cancer (NIMBC). Approval was ...
TG Therapeutics remains a Strong Buy as BRIUMVI drives robust revenue growth and pipeline expansions. Learn more about TGTX ...
Encouraging safety and preliminary efficacy analysis from the elacestrant and capivasertib Phase 1b regimen of the ELEVATE study will be presented.The efficacy data highlight how the combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results